X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21830) 21830
Publication (4321) 4321
Book Chapter (283) 283
Book Review (162) 162
Conference Proceeding (83) 83
Dissertation (55) 55
Magazine Article (18) 18
Data Set (16) 16
Streaming Video (12) 12
Newspaper Article (11) 11
Newsletter (7) 7
Book / eBook (5) 5
Government Document (5) 5
Web Resource (5) 5
Reference (4) 4
Journal / eJournal (3) 3
Trade Publication Article (2) 2
Standard (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13158) 13158
humans (11648) 11648
animals (10568) 10568
neutralizing antibodies (6673) 6673
immunology (6457) 6457
female (5200) 5200
mice (5104) 5104
virology (5075) 5075
antibodies (4843) 4843
viruses (4645) 4645
antibodies, neutralizing - immunology (4508) 4508
vaccines (4054) 4054
male (3448) 3448
infectious diseases (3261) 3261
infection (3197) 3197
antibodies, neutralizing - blood (3077) 3077
antibodies, viral - blood (3075) 3075
vaccination (2809) 2809
neutralization tests (2789) 2789
microbiology (2677) 2677
proteins (2633) 2633
antibodies, viral - immunology (2496) 2496
immunization (2462) 2462
medicine, research & experimental (2457) 2457
health aspects (2446) 2446
infections (2439) 2439
vaccine (2376) 2376
virus diseases (2359) 2359
neutralizing antibody (2337) 2337
hiv-1 - immunology (2192) 2192
article (2005) 2005
research (1978) 1978
hiv (1925) 1925
mice, inbred balb c (1925) 1925
adult (1891) 1891
immunogenicity (1881) 1881
antigens (1872) 1872
analysis (1861) 1861
molecular sequence data (1758) 1758
amino acid sequence (1738) 1738
immunoglobulins (1709) 1709
monoclonal-antibodies (1701) 1701
viral antibodies (1686) 1686
immune response (1642) 1642
research article (1641) 1641
enzyme-linked immunosorbent assay (1639) 1639
multidisciplinary sciences (1633) 1633
cell line (1631) 1631
neutralizing (1592) 1592
biochemistry & molecular biology (1518) 1518
immunity (1492) 1492
antibodies, monoclonal - immunology (1479) 1479
hiv infections - immunology (1479) 1479
medicine (1419) 1419
disease models, animal (1403) 1403
viral vaccines - immunology (1398) 1398
monoclonal antibodies (1383) 1383
middle aged (1369) 1369
hiv antibodies - immunology (1353) 1353
biotechnology & applied microbiology (1341) 1341
epitopes - immunology (1301) 1301
allergy and immunology (1229) 1229
neutralization (1219) 1219
expression (1197) 1197
viral envelope proteins - immunology (1195) 1195
human-immunodeficiency-virus (1159) 1159
immune-responses (1142) 1142
aids vaccines - immunology (1117) 1117
antibodies, neutralizing - pharmacology (1104) 1104
immunodeficiency-virus type-1 (1103) 1103
epitopes (1102) 1102
protection (1102) 1102
medical research (1052) 1052
cell biology (1050) 1050
science (1050) 1050
hiv-1 (1038) 1038
biology (1008) 1008
antigenic determinants (997) 997
human immunodeficiency virus--hiv (993) 993
virus (962) 962
glycoprotein (947) 947
adolescent (943) 943
protein (924) 924
identification (915) 915
mice, inbred c57bl (911) 911
disease (897) 897
hiv envelope protein gp120 - immunology (892) 892
binding (887) 887
prevention (887) 887
pharmacology & pharmacy (863) 863
cells (862) 862
veterinary sciences (858) 858
vaccines, synthetic - immunology (856) 856
influenza (853) 853
young adult (852) 852
mutation (850) 850
glycoproteins (849) 849
gene expression (844) 844
antibody (841) 841
immune system (839) 839
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21656) 21656
Japanese (193) 193
Chinese (131) 131
German (81) 81
French (70) 70
Russian (50) 50
Spanish (41) 41
Portuguese (23) 23
Italian (22) 22
Korean (21) 21
Czech (12) 12
Romanian (6) 6
Polish (5) 5
Dutch (3) 3
Hungarian (2) 2
Croatian (1) 1
Norwegian (1) 1
Persian (1) 1
Slovenian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science, ISSN 0036-8075, 11/2011, Volume 334, Issue 6059, pp. 1097 - 1103
The HIV envelope (Env) protein gpl20 is protected from antibody recognition by a dense glycan shield. However, several of the recently identified PGT broadly... 
Polysaccharides | HIV | Neutralizing antibodies | RESEARCH ARTICLES | Antibodies | Viruses | Trimers | Epitopes | Grants | Binding sites | Crystal structure | PANEL | TRIMERS | MULTIDISCIPLINARY SCIENCES | IMMUNOGENS | ENVELOPE GLYCOPROTEIN COMPLEX | GP120 | HUMAN-IMMUNODEFICIENCY-VIRUS | MONOCLONAL-ANTIBODIES | TYPE-1 | Antibody Specificity | Mannose - immunology | Disaccharides - metabolism | Humans | Antibodies, Neutralizing - metabolism | Crystallography, X-Ray | Disaccharides - chemistry | Mannosides - chemistry | HIV Envelope Protein gp120 - metabolism | HIV Envelope Protein gp120 - immunology | Mannose - metabolism | Antibodies, Neutralizing - immunology | HIV-1 - physiology | HIV Antibodies - immunology | Immunoglobulin Fab Fragments - metabolism | Oligosaccharides - chemistry | Polysaccharides - chemistry | HIV Envelope Protein gp120 - chemistry | Mannose - chemistry | HIV Antibodies - metabolism | Protein Structure, Tertiary | Cell Line | Models, Molecular | Antibodies, Neutralizing - genetics | Glycosylation | Polysaccharides - immunology | Oligosaccharides - metabolism | HIV Antibodies - chemistry | Polysaccharides - metabolism | HIV-1 - immunology | Hydrogen Bonding | Antibodies, Neutralizing - chemistry | Immunoglobulin Fab Fragments - chemistry | Oligosaccharides - immunology | Protein Conformation | Mannosides - metabolism | HIV Antibodies - genetics | Immunoglobulin Fab Fragments - immunology | Mutation | Binding Sites, Antibody | Carbohydrate Conformation | Viral antibodies | Physiological aspects | Development and progression | Glycoproteins | HIV (Viruses) | Health aspects | Proteins | Antigens | Immunoglobulins | Human immunodeficiency virus--HIV
Journal Article
Nature, ISSN 0028-0836, 06/2015, Volume 522, Issue 7557, pp. 487 - 491
HIV-1 immunotherapy with a combination of first generation monoclonal antibodies was largely ineffective in pre-clinical and clinical settings and was... 
THERAPY | VIRUS | HIV-1 NEUTRALIZATION | GENETIC-DETERMINANTS | IMMUNOTHERAPY | MULTIDISCIPLINARY SCIENCES | PASSIVE TRANSFER | IN-VIVO | VACCINE | MICE | MONOCLONAL-ANTIBODIES | Antibodies, Neutralizing - administration & dosage | Humans | Middle Aged | Viremia - therapy | Molecular Sequence Data | Antibodies, Monoclonal - therapeutic use | Male | Case-Control Studies | HIV Envelope Protein gp120 - immunology | Young Adult | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - adverse effects | HIV Antibodies - immunology | Time Factors | HIV-1 - chemistry | Antibodies, Neutralizing - therapeutic use | Adult | Antibodies, Neutralizing - adverse effects | Female | HIV Antibodies - therapeutic use | HIV Envelope Protein gp120 - chemistry | HIV Antibodies - pharmacology | Binding Sites | Antibodies, Monoclonal - immunology | Amino Acid Sequence | Immunization, Passive - methods | HIV-1 - drug effects | HIV Infections - virology | Antibodies, Monoclonal - pharmacokinetics | Antibodies, Neutralizing - pharmacology | HIV Antibodies - administration & dosage | Viral Load - immunology | HIV-1 - immunology | Viremia - virology | Antibodies, Monoclonal - administration & dosage | HIV Infections - therapy | Viremia - immunology | Viral Load - drug effects | CD4 Antigens - metabolism | Evolution, Molecular | Viral antibodies | Virus diseases | Physiological aspects | Antibodies | HIV infection | Antigens | Immunoglobulins | Human immunodeficiency virus--HIV | Immunotherapy | Infections | Drug dosages | Binding sites | Immune system
Journal Article
Nature Immunology, ISSN 1529-2908, 08/2016, Volume 17, Issue 9, pp. 1102 - 1108
Zika virus (ZIKV) was discovered in 1947 and was thought to lead to relatively mild disease. The recent explosive outbreak of ZIKV in South America has led to... 
NEUTRALIZING ANTIBODIES | IMMUNOLOGY | CHIKUNGUNYA VIRUS | OUTBREAK | BRAZIL | BRAIN | Immunodominant Epitopes - immunology | Antibody-Dependent Enhancement | Epitope Mapping | Humans | Child, Preschool | Male | Antibodies, Viral - blood | Microcephaly - epidemiology | Antibodies, Monoclonal - blood | Antibodies, Neutralizing - immunology | South America - epidemiology | Immunodominant Epitopes - metabolism | Guillain-Barre Syndrome - epidemiology | Viral Envelope Proteins - metabolism | Female | Dengue - immunology | Child | Antibodies, Monoclonal - immunology | Zika Virus - physiology | Cells, Cultured | Dengue - epidemiology | Cross Reactions | Zika Virus Infection - epidemiology | Virus Replication | Adolescent | Protein Binding | Zika Virus Infection - immunology | Antibodies, Viral - immunology | Dengue Virus - physiology | Viral Envelope Proteins - immunology | Antibodies, Neutralizing - blood | Medical research | Immune response | Comorbidity | Dengue | Medicine, Experimental | Development and progression | Research | Observations | South America | Populations and Evolution | Viral Envelope Proteins | Zika Virus Infection | Microcephaly | Guillain-Barre Syndrome | Life Sciences | Computer Science | Genetics | Bioinformatics | Antibodies, Neutralizing | Parasitology | Quantitative Methods | Zika Virus | Antibodies, Monoclonal | Antibodies, Viral | Dengue Virus | Virology | Microbiology and Parasitology | Santé publique et épidémiologie | Immunodominant Epitopes | Human genetics
Journal Article
Science, ISSN 0036-8075, 9/2011, Volume 333, Issue 6049, pp. 1593 - 1602
Antibody VRC01 is a human immunoglobulin that neutralizes about 90% of HIV-1 isolates. To understand how such broadly neutralizing antibodies develop, we used... 
Germ cells | Neutralizing antibodies | B lymphocytes | RESEARCH ARTICLES | Genomics | Alleles | Antibodies | Phylogenetics | Epitopes | HIV 1 | High throughput nucleotide sequencing | DESIGN | DOMAIN | EPITOPE | MULTIDISCIPLINARY SCIENCES | BROAD | DIVERSITY | GLYCOPROTEIN | GP120 | MONOCLONAL-ANTIBODIES | SELECTION | BREADTH | Antibody Specificity | Complementarity Determining Regions - genetics | Humans | Immunoglobulin Heavy Chains - chemistry | Molecular Sequence Data | Crystallography, X-Ray | HIV Antibodies - isolation & purification | HIV Envelope Protein gp120 - metabolism | Genes, Immunoglobulin Heavy Chain | HIV Envelope Protein gp120 - immunology | Immunoglobulin Light Chains - chemistry | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - immunology | HIV-1 - chemistry | Immunoglobulin J-Chains - genetics | Base Sequence | HIV Envelope Protein gp120 - chemistry | Binding Sites | Immunoglobulin Heavy Chains - immunology | Immunoglobulin Light Chains - immunology | Amino Acid Sequence | Models, Molecular | Antibody Affinity | Antibodies, Neutralizing - genetics | HIV Antibodies - chemistry | Sequence Analysis, DNA | Antibodies, Neutralizing - isolation & purification | HIV-1 - immunology | Antibodies, Neutralizing - chemistry | Immunoglobulin Fab Fragments - chemistry | AIDS Vaccines | High-Throughput Nucleotide Sequencing | HIV Antibodies - genetics | Immunoglobulin Fab Fragments - immunology | Mutation | Binding Sites, Antibody | CD4 Antigens - metabolism | Evolution, Molecular | Viral antibodies | X-ray crystallography | Immunoglobulins | Physiological aspects | Genetic aspects | HIV (Viruses) | Health aspects | Methods | ANTIBODIES | IMMUNITY | BASIC BIOLOGICAL SCIENCES | GENETICS | IMMUNOGLOBULINS | CRYSTAL STRUCTURE | CRYSTALLOGRAPHY | CHAINS | 60 APPLIED LIFE SCIENCES | FUNCTIONALS
Journal Article
Science, ISSN 0036-8075, 10/2017, Volume 358, Issue 6359, pp. 85 - 90
Journal Article
Nature, ISSN 0028-0836, 05/2016, Volume 533, Issue 7601, pp. 105 - 109
Despite the success of potent anti-retroviral drugs in controlling human immunodeficiency virus type 1 (HIV-1) infection, little progress has been made in... 
SIMIAN/HUMAN IMMUNODEFICIENCY VIRUS | POTENT | TRANSMISSION | HIV-1/SIV CHIMERIC VIRUS | BROADLY NEUTRALIZING ANTIBODY | MULTIDISCIPLINARY SCIENCES | IMPROVES PROTECTION | PASSIVE TRANSFER | MACAQUES | INFECTION | MONOCLONAL-ANTIBODIES | HIV Antibodies - blood | Antibodies, Neutralizing - administration & dosage | HIV Infections - prevention & control | AIDS Vaccines - immunology | Macaca mulatta - immunology | Half-Life | Male | Antibodies, Monoclonal - blood | HIV Infections - immunology | Macaca mulatta - virology | Antibodies, Neutralizing - immunology | Immunoglobulin Fc Fragments - immunology | HIV Antibodies - immunology | Time Factors | Female | HIV Infections - transmission | Antibodies, Monoclonal - immunology | Simian Immunodeficiency Virus - immunology | Protein Structure, Tertiary | SAIDS Vaccines - administration & dosage | Immunoglobulin Fc Fragments - chemistry | Antibodies, Neutralizing - genetics | Mutation - genetics | Simian Acquired Immunodeficiency Syndrome - blood | HIV Antibodies - administration & dosage | Simian Acquired Immunodeficiency Syndrome - prevention & control | Antibodies, Monoclonal - genetics | Animals | SAIDS Vaccines - immunology | Simian Acquired Immunodeficiency Syndrome - immunology | Antibodies, Monoclonal - administration & dosage | HIV Antibodies - genetics | AIDS Vaccines - administration & dosage | Immunoglobulin Fc Fragments - genetics | Antibodies, Neutralizing - blood | Prevention | Viral antibodies | Antibodies | Dosage and administration | HIV infection | Patient outcomes | Monoclonal antibodies | Immunoglobulins | Immunization | Vaccines | Human immunodeficiency virus--HIV | Viral infections
Journal Article
Journal Article
Nature, ISSN 0028-0836, 06/2019, Volume 570, Issue 7762, pp. 468 - 473
Broadly neutralizing monoclonal antibodies protect against infection with HIV-1 in animal models, suggesting that a vaccine that elicits these antibodies would... 
TARGET | RECOGNITION | AFFINITY | BROADLY NEUTRALIZING ANTIBODIES | MULTIDISCIPLINARY SCIENCES | VACCINE | ENVELOPE GLYCOPROTEIN | VALIDATION | VULNERABILITY | IDENTIFICATION | SUPERSITE | Immunodominant Epitopes - immunology | Clone Cells - cytology | Cell Proliferation | Vaccination | AIDS Vaccines - immunology | Macaca mulatta - immunology | Antibodies, Neutralizing - ultrastructure | Male | Antibodies, Neutralizing - immunology | Antibody Specificity - immunology | HIV Antibodies - immunology | HIV-1 - chemistry | Clone Cells - immunology | Cloning, Molecular | Female | Immunodominant Epitopes - ultrastructure | Amino Acid Sequence | Rabbits | B-Lymphocytes - cytology | Somatic Hypermutation, Immunoglobulin | Immunodominant Epitopes - chemistry | Lymphocyte Activation | Models, Molecular | Antibody Affinity | Antibodies, Neutralizing - genetics | Polysaccharides - immunology | HIV Antibodies - chemistry | Cryoelectron Microscopy | HIV Antibodies - ultrastructure | HIV-1 - immunology | Animals | B-Lymphocytes - immunology | Cross-Priming - immunology | Antibodies, Neutralizing - chemistry | Mice | HIV Antibodies - genetics | Antigen-Antibody Complex - immunology | AIDS vaccines | AIDS (Disease) | Monoclonal antibodies | Physiological aspects | B cells | Research | AIDS research | Immunological research | Animal models | Viruses | Vaccines | Virus-like particles | Design | Polysaccharides | Precursors | Human immunodeficiency virus--HIV | Antigens | Immunization | Immunoglobulins | Automation | Cloning | Envelope protein | Priming | Electron microscopy | Glycan | Microscopy | Lymphocytes B | Neutralizing | Mutation | Binding sites
Journal Article